New liposomal painkiller could improve knee surgery recovery

NCT ID NCT07366905

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a long-acting form of the painkiller bupivacaine (liposomal bupivacaine) for nerve blocks in the thigh during knee surgery. Researchers aimed to find the best dose to numb sensation and block movement. 79 adults having knee surgery took part, and the results will help guide future pain management.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

liposomal bupivacaine

What this could lead to

If successful, this could help doctors use the right dose of liposomal bupivacaine for better pain control during knee surgery.

What could go wrong

This is a small, early-phase study focused on finding the right dose, not on proving effectiveness. Results may not apply to all patients or surgeries.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PATIENTS ELIGIBLE FOR ELECTIVE LOWER EXTREMITY FEMORAL NERVE SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Anesthesiology,the Second Affiliated Hospital of Hainan Medical University

    Haikou, Hainan, China